Sulfalene
|  | |
| Clinical data | |
|---|---|
| Trade names | Eadazine, Kelfizina, Kelfizine W, Longum | 
| AHFS/Drugs.com | International Drug Names | 
| Routes of administration | Oral[1] | 
| ATC code | J01ED02 (WHO) QJ01EQ19 (WHO) | 
| Pharmacokinetic data | |
| Protein binding | 60 to 80%[1] | 
| Biological half-life | 60 to 65 hours[1] | 
| Excretion | Urinary[1] | 
| Identifiers | |
| 
 | |
| Synonyms | Sulfametopyrazine | 
| CAS Number | 152-47-6  | 
| PubChem (CID) | 9047 | 
| DrugBank | DB00664  | 
| ChemSpider | 8695  | 
| UNII | T6BL4ZC15G  | 
| KEGG | D01216  | 
| ECHA InfoCard | 100.005.278 | 
| Chemical and physical data | |
| Formula | C11H12N4O3S | 
| Molar mass | 280.304 g/mol | 
| 3D model (Jmol) | Interactive image | 
| 
 | |
| 
 | |
| (verify) | |
Sulfalene (INN, USAN) or sulfametopyrazine (BAN) is a long-acting sulfonamide antibacterial used for the treatment of chronic bronchitis, urinary tract infections and malaria.[2][3] As of 2014 there were only two countries in which it is currently still marketed: Thailand and Ireland.[3]
It was discovered by researchers at Farmitalia and first published in 1960 and was marketed as Kelfizina.[4][5]
See also
References
- 1 2 3 4 "Sulfalene". MIMS Drug Information System. Retrieved 26 August 2011.
- ↑ DrugBank DB00664
- 1 2 Brayfield, A, ed. (9 May 2013). "Sulfametopyrazine". Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 28 March 2014.
- ↑ Baruffa G. Clinical trials in Plasmodium falciparum malaria with a long-acting sulphonamide. Trans R Soc Trop Med Hyg. 1966;60(2):222-4. PMID 5332105
- ↑ Per prior citation, the first publication: Camerino B, Palamidessi G (1960) Derivati della parazina II. Sulfonamdopir (in Italian). Gazz Chim Ital 90:1802–1815
This article is issued from Wikipedia - version of the 4/17/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.